Share
Linkedin
Twitter
Facebook
Whatsapp
Copy Link
OpenAI announced its AI solved the 26-year-old Navier-Stokes problem in half a week, sparking plagiarism accusations and fierce debate. Mathematician Tristan Buckmaster raised concerns about potential data misuse, while 27 Field Medal recipients warned AI-generated solutions could damage mathematical progress by bypassing crucial human insight.
University of California San Diego researchers developed two approaches to create virtual cells that mimic real biological processes. One uses a deep-learning model called MitoSpace trained on 40,000 4D movies to predict cellular health. The other builds physics-based digital twins that accurately simulate mitochondrial dynamics and drug responses.
Anthropic announced its Claude AI model autonomously discovered a previously unknown enzyme system with properties similar to CRISPR gene-editing technology. The discovery took just 21 hours using 950 AI agents analyzing 210 million tokens at the company's new wet biology lab in the San Francisco Bay Area.
Beacon Software acquired Haize Labs to form an Applied AI Research Group that will deploy enterprise-grade AI capabilities across its 45-company portfolio. The Toronto holding company aims to bring sophisticated AI tools—previously available only to Fortune 500 firms—to Main Street software businesses serving campgrounds, construction companies, and other essential industries.
Anthropic disclosed that its AI model Claude now leads 26% of the company's research and development work, a dramatic jump from zero in February. The San Francisco-based startup shared three new metrics to help the industry monitor the pace of AI development, amid growing concerns about AI systems building their own successors with minimal human input.
Stanford researchers unveiled Paper2Agent, an open-source AI framework that converts scientific papers into interactive agents. Published in Nature, the tool turns static research into dynamic AI collaborators that can reproduce analyses, apply methods to new data, and even discover new connections between studies—like identifying MPHOSPH9's link to ADHD risk.
Emulate, founded by former Google DeepMind researchers in August, is closing a $700 million funding round at a $3.7 billion valuation. The AI startup focuses on world models that generate interactive 3D environments, marking the third major spinout from DeepMind's London offices this year as venture capitalists compete for top AI research talent.
MIT researchers unveiled xvr, an AI model that adapts to individual patients in five minutes and matches real-time X-rays with preoperative 3D scans in seconds with sub-millimeter precision. Published in Nature, the system outperformed existing AI methods by an order of magnitude and could make life-saving procedures like emergency stroke interventions more accessible.
IonQ presented research at IEEE Quantum Week showing how a trained generative AI model can create quantum optimization circuits directly, eliminating costly parameter tuning loops. The collaboration with Oak Ridge National Laboratory, NVIDIA, and University of Tennessee demonstrated that circuit-finding time dropped from over 11 minutes to approximately 28 seconds while improving solution quality.
Major AI labs including Anthropic and OpenAI report significant progress toward recursive self-improvement, where AI systems autonomously enhance their own capabilities. Anthropic's Claude now leads 26% of model R&D work, while industry leaders including Dario Amodei and Sam Altman call for slowing development pace amid fears of runaway superintelligence and loss of human control.
ByteDance has completed a $290 million fundraising round for Anew Labs, its newly independent AI drug discovery unit, achieving a $1.5 billion valuation. The ByteDance spin-off attracted leading investors including HSG, IDG Capital, and Hillhouse Investment, while ByteDance retains 56% ownership of the Shanghai-based company.
Insilico Medicine announced Longevity Vaccines, a research initiative using AI-driven drug discovery to develop single-dose therapies that eliminate senescent cells. The programmable circular RNA platform targets cellular drivers of age-related diseases, starting with immunosenescence. The company reported $106 million revenue in H1 2026, marking its first profitable half-year.
Seattle-based Nuance Labs raised $50 million in Series A funding to develop a full-duplex foundational AI model that perceives and responds to real-time human expression. Founded by former Apple researchers, the startup aims to fix the awkwardness of AI avatars by processing tone, gaze, and conversational cues simultaneously rather than chaining separate tools together.
OpenAI announced its AI model solved the Millennium Prize Problem related to Navier-Stokes equations, proving they can produce singularities. But the claim sparked fierce debate over credit attribution, with mathematicians questioning whether AI tools absorbed unpublished work and whether the solution addresses the problem they actually care about.
Stanford Medicine researchers developed TranscriptFormer, an AI model trained on 112 million cells from 12 species that maps gene expression patterns across organisms. The model can identify cell types in new species, distinguish healthy from diseased cells, and may eventually guide designing new cell-based treatments for complex diseases.
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.